Medico Remedies Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medico Remedies Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 90% of Healthcare companies in India.
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 88% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹42Over the last 3 years, every ₹100 of reported profit came with ₹42 of operating cash.
Lower than 83% of Healthcare companies in India.
Self-Funding Ratio
1.3×Over the last 3 years its own operating cash covered its investment spending (capex) 1.3 times.
Lower than 53% of Healthcare companies in India.
Cash Locked Ratio
₹30For every ₹100 of sales, ₹30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹17 tied up three years earlier.
More money tied up than 61% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹9Sales grew 47% in 3 years; of every extra ₹100 of sales, ₹9 became extra profit.
Lower than 71% of Healthcare companies in India.
Asset Productivity Ratio
+47% / +75%In 3 years sales changed by +47% while total assets changed by +75%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.3×Debt due within a year is covered 0.3 times by its yearly operating cash.
Lower than 76% of Healthcare companies in India.
Cash Cushion Ratio
−9%Debt, after subtracting cash, equals 9% of its market value (net debt).
Lower than 75% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 90% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 88% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Medico Remedies Limited owes ₹0.51 for every ₹1 it owns. Net profit rose 30% in the year to Mar 2026, and grew 22% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
12.3Investors pay ₹12.3 for every ₹1 of Medico Remedies Limited's yearly profit, lower than 93% of Healthcare companies in India.
P/B ratio
2.25The share price is 2.25 times Medico Remedies Limited's book value per share, lower than 81% of Healthcare companies in India.
Market cap
₹170 CrThe total market value of all of Medico Remedies Limited's shares at today's price (share price × number of shares), smaller than 92% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹75 CrWhat Medico Remedies Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹9.10Net worth divided by the number of shares. The share price of ₹20.50 is 2.3 times this, which is the P/B above.
Return on equity (ROE)
18.2%Medico Remedies Limited earned 18.2% on its shareholders' money over the last year, higher than 75% of Healthcare companies in India.
Owes vs Owns
0.51×Medico Remedies Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 86% of Healthcare companies in India.
Dividend yield
NoneMedico Remedies Limited does not currently pay a dividend.
Revenue growth
+37%Revenue rose 37% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Profit growth
+30%Net profit rose 30% in the year to Mar 2026, and grew 22% a year on average over 3 years.
Profit margin
6.4%Medico Remedies Limited keeps ₹6 of every ₹100 of revenue as net profit.
Cash quality
0.4×Cash from Medico Remedies Limited's business was 0.4× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
14.1×Medico Remedies Limited's operating profit covered its interest costs 14.1 times in the year to Mar 2026.
Cash vs debt
Net debtMedico Remedies Limited had ₹16 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Medico Remedies Limited's P/E ratio?
Investors pay ₹12.3 for every ₹1 of Medico Remedies Limited's yearly profit, lower than 93% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medico Remedies Limited: ₹170 Cr ÷ ₹75 Cr (31 Mar 2026) = 2.3.
What is Medico Remedies Limited's return on equity?
Medico Remedies Limited earned 18.2% on its shareholders' money over the last year, higher than 75% of Healthcare companies in India.
How much does Medico Remedies Limited owe compared with what it owns?
Medico Remedies Limited owes ₹0.51 for every ₹1 it owns (moderate), higher than 86% of Healthcare companies in India.
Does Medico Remedies Limited pay a dividend?
No. Medico Remedies Limited does not currently pay a dividend.
Is Medico Remedies Limited's revenue growing?
Revenue rose 37% in the year to Mar 2026, and grew 14% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.